Global Diagnostic Electrocardiograph (ECG) Market 2024-2028
The diagnostic electrocardiograph (ECG) market is forecasted to grow by USD 4356.94 mn during 2023-2028, accelerating at a CAGR of 8.49% during the forecast period. The report on the diagnostic electrocardiograph (ECG) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased incidence of cardiac disorders, increasing focus on preventive treatment, and increasing number of heart specialty centers.
Technavio's diagnostic electrocardiograph (ECG) market is segmented as below:
By End-user
- Hospitals/clinics/cardiac care centers
- Ambulatory surgical centers
- Home setting
By Product
- Resting ECG
- Stress
- Mobile cardiac telemetry device
- Implantable loop recorder
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the integration of technologies to develop advanced diagnostic ECG as one of the prime reasons driving the diagnostic electrocardiograph (ECG) market growth during the next few years. Also, emergence of remote monitoring diagnostic ECG and increasing uptake of MCT will lead to sizable demand in the market.
The report on the diagnostic electrocardiograph (ECG) market covers the following areas:
- Diagnostic electrocardiograph (ECG) market sizing
- Diagnostic electrocardiograph (ECG) market forecast
- Diagnostic electrocardiograph (ECG) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diagnostic electrocardiograph (ECG) market vendors that include ACS Diagnostics Inc., Allengers Medical Systems Ltd., Ambu AS, Baxter International Inc., Bionet America, BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Cardioline SpA, EDAN Instruments Inc., Fukuda Denshi Co. Ltd., General Electric Co., Innomed Medical Inc., Koninklijke Philips N.V., Midmark Corp., Mindray Bio medical Electronics Co. Ltd., NEXUS LIFECARE PVT. LTD., Nihon Kohden Corp., Norav Medical, OSI Systems Inc., SCHILLER AG, and VectraCor Inc.. Also, the diagnostic electrocardiograph (ECG) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.